Impact of malignant disease on young adultsBreast Cancer Before Age 40 Years
Section snippets
Epidemiology
The American Cancer Society (ACS) estimates that 182,460 women in the United States were diagnosed with breast cancer in 2008 and that 40,480 women died of the disease during the year.2 The incidence of breast cancer appears to have a sigmoid function in women less than 55 years of age (Figure 1, lower panel), with 6.6% of all cases diagnosed before age 40, 2.4% diagnosed before age 35, and 1% diagnosed before age 30 (Figure 2, inset). The individual average risk of a woman developing breast
Clinicopathologic Features, Biology, and Prognosis
The comparison of clinicopathologic and prognostic features of breast cancer arising in younger women with those in their older counterparts has been the subject of published studies for decades.27, 28, 29 Traditionally, breast cancer arising in a younger host is characterized by a more aggressive phenotype. Among 185 premenopausal women carrying a diagnosis of invasive breast cancer, referred for surgery at the European Institute of Oncology from April 1997 to August 2000, those aged less than
Treatment and Management
Although the principles of managing invasive breast cancer in adolescent girls and young women are the same as in older women, there are a number of management and therapeutic issues requiring special consideration. Adolescents and young women are at particular risk of emotional and psychosocial problems, and require appropriate support from age- and disease-specific psychosocial and medical multidisciplinary teams.39
For many reasons, including development, function, body image, and quality of
Outcomes
Across all histologic subtypes and stages, breast cancer survival rates are comparatively lower for women <40 years of age than for older women.13 The lowest overall rate of cancer survival for females diagnosed during 2000-2005 was in those aged 25-29 years (72% 5-year relative survival), followed by 20- to 24-year-olds and 30- to 34-year-olds (75% and 76%, respectively) and 35- to 39-year-olds (80%) (Figure 5). In contrast, relative survival for women between age 45 and 80 years was 84%-86% (
Fertility and Pregnancy
Young women undergoing chemotherapy for breast cancer may struggle with fertility and pregnancy issues. To that end, the American Society of Clinical Oncology has published guidelines to address infertility.68 Unfortunately, there is no way to measure fertility other than to follow patients for subsequent pregnancies and the use of amenorrhea as a surrogate marker for infertility, which is imperfect. Also, many women may continue or resume menses months after the administration of chemotherapy.
Pregnancy and Breast Cancer
Current estimates of breast cancer during pregnancy are 1.3 cases per 10,000 births73 and, when cancer is diagnosed in women 30 years old or younger, an estimated 10%-20% of cancers are detected either during pregnancy or within the first year postpartum.74, 75
Bone Health
As a majority of young women diagnosed with early-stage breast cancer will survive many years following diagnosis and treatment, bone loss associated with both adjuvant endocrine and cytotoxic chemotherapeutics must be taken into consideration to prevent long-term complications including osteopenia, osteoporosis, and potentially disabling fractures. Traditionally, the postmenopausal breast cancer population had been the focus of bone health research, given the success of aromatase inhibitors,
Inherited Breast Cancer and Risk Reduction
Family history is a known risk factor for breast cancer, with elevated risk due to both increasing number and decreasing age of first-degree relatives affected. For example, in a large, population-based study, risk of breast cancer was increased 2.9-fold among women whose relative was diagnosed prior to age 30, but the increase was only 1.5-fold if the affected relative was diagnosed after age 60 years.90 While twin studies indicate familial aggregation among women diagnosed with breast cancer,
Psychosocial Issues
Although a diagnosis of breast cancer can be distressing to patients across all age groups, diagnosis at a younger age presents a variety of unique psychosocial and emotional challenges, including, but not limited to, interactions with spouse/children, body image, sexuality, and loss of fertility/premature menopause.69, 100 A retrospective study evaluating more than 500 breast cancer survivors aged 25-50 years illustrated that emotional and social functioning, vitality, and depression 6 years
Conclusions
Although thought to be a relatively uncommon condition, potentially one third of all breast cancers are diagnosed among premenopausal women. Breast cancers diagnosed at a younger age harbor aggressive clinicopathologic features and, more recently, have been recognized as a unique biologic entity. Special considerations, including infertility, pregnancy, bone health, genetic syndromes, and psychosocial issues must be addressed when developing treatment algorithms, including local therapies and
References (102)
- et al.
Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk
Med Hypoth
(2007) - et al.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
Am J Hum Genet
(2003) - et al.
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives
Eur J Cancer
(2006) - et al.
Physical activity and breast cancer risk among women in the southwestern United States
Ann Epidemiol
(2007) - et al.
Regular use of multivitamin-multimineral supplements may be associated with higher mean breast density among premenopausal women
Am J Clin Nutr
(2008) - et al.
Effect of age on the survival of breast cancer patients
Eur J Cancer
(1997) - et al.
Very young women (<35 years) with operable breast cancer: features of disease at presentation
Ann Oncol
(2002) - et al.
Age as prognostic factor in premenopausal breast carcinoma
Lancet
(1993) - et al.
Breast cancer in adolescents and young women
Eur J Cancer
(2003) - et al.
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Lancet
(2000)
The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients
Ann Oncol
Is breast cancer in young Latinas a different disease?
Am J Surg
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers
Fertil Steril
Emerging therapeutic options for breast cancer chemotherapy during pregnancy
Ann Oncol
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
Lancet Oncol
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer familiesThe Breast Cancer Linkage Consortium
Am J Hum Genet
SEER Cancer Statistics Review, 1975-2005
Cancer statistics, 2008
CA Cancer J Clin
The decrease in breast-cancer incidence in 2003 in the United States
N Engl J Med
Breast cancers among very young premenopausal women (United States)
Cancer Causes Control
Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35
Cancer
Cancer in American Indian and Alaska Native young adults (ages 20-44 years): US, 1999-2004
Cancer
Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology
J Natl Med Assoc
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study
Cancer Causes Control
Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004
Cancer
Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. NIH Publication No. 06-5767
Energy balance and breast cancer risk: a prospective cohort study
Breast Cancer Res Treat
Evidence of poorer survival in pregnancy-associated breast cancer
Obstet Gynecol
Red meat intake and risk of breast cancer among premenopausal women
Arch Intern Med
Fruits, vegetables, soy foods and breast cancer in pre- and postmenopausal Korean women: a case-control study
Int J Vitam Nutr Res
Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis
Cancer Epidemiol Biomarkers Prev
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer
Cancer Epidemiol Biomarkers Prev
Breast cancer racial differences before age 40—implications for screening
J Nat Med Assoc
Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study
Nutr Cancer
Evidence that high calcium and vitamin D intake decrease the risk of breast cancer in premenopausal women: implications for breast cancer prevention and screening
South Med J
Intakes of calcium and vitamin D and breast cancer risk in women
Arch Intern Med
Vitamin D and calcium intakes from food or supplements and mammographic breast density
Cancer Epidemiol Biomarkers Prev
The relation between survival and age at diagnosis and breast cancer
N Engl J Med
Effects of young age at presentation on survival in breast cancer
BMC Cancer
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
J Clin Oncol
Breast cancer outcomes and predictors of outcome: are there age differentials?
J Natl Cancer Inst Monogr
Early onset breast cancer—histopathological and prognostic considerations
Br J Cancer
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I and II breast cancer
J Clin Oncol
Elevated breast cancer mortality in young women (<40 yrs) compared with older women is attributed to poorer survival in early stage disease
J Clin Oncol
Younger women diagnosed with early-stage breast cancer more likely to die than older women
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
Breast Cancer Res Treat
Why are local recurrences after breast-conserving therapy more frequent in younger patients?
J Clin Oncol
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials
J Clin Oncol
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast CancerSeventh International Conference on Adjuvant Therapy of Primary Breast Cancer
J Clin Oncol
Factors influencing the effect of age on prognosis in breast cancer: population based study
BMJ
Cited by (560)
Young Age as a Predictor of Chemotherapy Recommendation and Treatment in Breast Cancer: A National Cancer Database Study
2024, Journal of Surgical ResearchCommunication with physicians and family about breast Cancer recurrence
2023, PEC InnovationEstrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
2023, Cancer Treatment Reviews